News | February 05, 2022
Mangalam Drugs and Organics Q3FY22 PAT at Rs. 4.02 crore
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
New instrument helps maximize lab productivity and extends FTIR to large, heavy samples
Fast, flexible space allows clinical trials to start when needed. A trial can become operational, pivot or scale without traditional capital building expenditures
Ascent Meditech has set benchmarks in introducing pain management products in India. The company has embarked on a new marketing campaign as it plans to enter new markets. Rajiv Mistry, Founder & Managing Director, Ascent Group shares his perspective with Thomas C Thottathil on the road ahead for the company and industry
Unlike “Fast PCR” platforms - which uses LAMP/Isothermal technology and not gold standard RT-PCR - CoviSwift has high accuracy and sensitivity and is suitable for airports and hospitals
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
It will enable the company to branch out to new geographies and strengthen its presence in South Africa
The acquisition of myPOLS Biotec complements Medix Biochemica’s leading portfolio of IVD raw materials and expands its reagent offerings for molecular diagnostics
Subscribe To Our Newsletter & Stay Updated
